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MYOCARDIAL VIABILITY
Relationship between the extent of non-viable myocardium
and regional left ventricular function in chronic ischemic
heart disease
ARUNARK KOLIPAKA,1,2 GEORGE P. CHATZIMAVROUDIS,1,2 RICHARD D. WHITE,1 MICHAEL L. LIEBER,3 and
RANDOLPH M. SETSER, D.SC.1,2,*
1Section of Cardiovascular Imaging, Division of Radiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
2Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio, USA
3Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Purpose. To define the relationship between left ventricular (LV) regional contractile function and the extent of myocardial scar in patients
with chronic ischemic heart disease and multi-vessel coronary artery disease. Methods. Twenty-three patients with chronic ischemic heart
disease and 5 healthy volunteers underwent magnetic resonance imaging (MRI). In patients, the relative area (Percent Scar) and transmural
extent (Transmurality) of myocardial infarction were computed from short-axis delayed enhancement images. In each image, myocardial
segments were categorized based on the extent of infarction they contained, with 6 categories each for Percent Scar and Transmurality:
normal, from healthy volunteers; and 0%; 1–25%, 26–50%, 51–75%, and > 76% from patients. In patients and volunteers, regional LV
function was quantified by absolute systolic wall thickening from cine images and midwall circumferential strain using tagged images.
Results. Compared to normal segments, regional LV function in patients was significantly diminished in all scar extent intervals, with wall
thickening 1 mm and strain 8% for all categories. Systolic wall thickening was reduced significantly in all categories above 50%
Percent Scar and above 25% Transmurality in patients, relative to corresponding 0% categories. Circumferential strain was significantly
reduced above 25% Percent Scar and above 25% Transmurality. Conclusions. In patients with chronic ischemic heart disease and multi-
vessel coronary artery disease, wall thickening was more sensitive to changes in scar Transmurality than to changes in Percent Scar.
However, circumferential strain was equally sensitive to both indices. In general, circumferential strain was more sensitive than wall
thickening to increases in scar extent.
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1. Introduction
Ischemic heart disease is the leading cause of chronic heart
failure in western society (1, 2). However, its effects on car-
diac function are not uniform, as the degree of dysfunction
varies with the relative quantities of ischemic, hibernating,
and infarcted myocardium in the left ventricle (LV).
Furthermore, the effects of ischemic heart disease are
exacerbated by LV remodeling and dilatation as the disease
progresses (1).
Magnetic resonance imaging (MRI) has proven a valuable
tool for quantifying the impact of ischemic heart disease (3).
The extent of non-viable myocardium can be directly vi-
sualized using delayed enhancement (DE) MRI (4, 5). Fur-
thermore, other MRI techniques enable assessment of LV wall
motion, intramyocardial mechanics, or myocardial perfusion
in order to differentiate regions of myocardium that are nor-
mal, inducibly ischemic, chronically ischemic (e.g. hibernat-
ing) or infarcted (3).
The relationship between the extent of non-viable LV
myocardium and regional cardiac function has been studied
previously in the setting of single-vessel coronary artery
disease (6, 7). In a dog model of acute myocardial infarction,
Lieberman et al. demonstrated an abrupt deterioration of
systolic wall thickening in segments with more than 20%
transmural extent of infarction (6). In a separate study,
involving patients with reperfused chronic infarcts, Mahrholdt
et al. (7) determined that systolic wall thickening was
diminished in segments containing more than 50% non-
viable myocardium. However, the relationship between the
extent of non-viable tissue and regional cardiac function in
patients presenting with multi-vessel chronic ischemic heart
disease has not been studied.
The purpose of the current study was to examine the
relationship between scar extent and regional myocardial
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function in patients with chronic ischemic heart disease and
multi-vessel coronary artery disease and to determine if the
relationship between scar and function is preserved, even with
the confounding effects of myocardial ischemia and hiberna-
tion. Further, the authors sought to determine whether
circumferential strain would be more sensitive than wall
thickening to the presence of myocardial scar in this
population as it has been previously established in patients
with acute myocardial infarction (8).
2. Materials and methods
2.1. Patient population
The study population consisted of 23 patients (20 male/3
female; age 59 ± 13 years) with known chronic ischemic
heart disease, referred for MRI assessment of myocardial
viability. All patients had a history of hemodynamically
significant atherosclerotic coronary artery disease, defined by
the presence of at least one coronary stenosis > 50%. Most
patients (22 of 23; 96%) had multi-vessel coronary artery
disease (2 vessels: n = 4, 17%; 3 vessels: n = 18, 78%). The
lone patient with single-vessel disease (left anterior descend-
ing artery) also had 20–30% stenoses in both the circumflex
and right coronary arteries as well as non-viable myocardium
present in territories supplied by these arteries (visualized
using DE-MRI). No patient presented with acute myocardial
infarction. All patients had previously documented congestive
heart failure symptoms; at the time of MRI, New York Heart
Association functional class was distributed as follows: class I
(n = 2, 9%), class II (n = 10, 43%), class III (n = 8, 35%),
class IV (n = 3, 13%). All imaging studies were clinically
indicated; further image analysis, for research purposes, was
approved by the local Institutional Review Board with a
waiver of individual consent.
In addition, five healthy volunteers, all men (age 23 ± 1
years), with no prior history of heart disease were also imaged.
2.2. Imaging procedure
Imaging was performed using a 1.5 T MRI scanner (Sonata,
Siemens Medical Solutions, Erlangen, Germany).
Short-axis DE-MRI images were acquired at the basal,
middle, and apical thirds of the LV, approximately 20 minutes
after intravenous injection of 0.2 mmol/kg Gadolinium-DTPA
(Magnevist, Berlex, Laboratories, Wayne, NJ). Fourteen of
23 patients (61%) were imaged using an inversion recovery
TurboFLASH sequence (4). The remaining 9 patients (39%)
were imaged using an inversion recovery TurboFlash
sequence with phase sensitive reconstruction (9). The imaging
parameters for either sequence included TE 4 msec, TR
8 msec, flip angle 30, TI 190–470 msec, 23 lines acquired
every other RR-interval, slice thickness 8–10 mm, FOV
300–360 mm, RFOV 80–100%, NSA 1, initial matrix 2562,
and a breath hold of 10–15 sec, depending upon the heart rate.
Cine MRI image loops were acquired at short-axis levels
covering the LV in each patient using a balanced steady state
free precession pulse sequence (TrueFISP). Imaging param-
eters included TE 1.5–1.65 msec, TR 25–43 msec, flip angle
49–65, slice thickness either 6 or 10 mm, FOVx 263–360
mm, FOVy 300–360 mm, initial matrix 256
2. The breath hold
was 10–15 sec depending on the heart rate.
Tagged MRI image loops were acquired in each patient
using a segmented TurboFLASH sequence at short-axis levels
identical to those specified for DE imaging above. Imaging
parameters included TE 2.7–4.8 msec, TR 25–66 msec, flip
angle 14–30, slice thickness 6–10 mm, FOVx 244–350
mm, FOVy 300–380 mm, initial matrix 256
2. Each breath
hold was 15–20 sec depending on heart rate.
In each healthy volunteer, short-axis cine MR image loops
and tagged image loops were acquired at the basal, middle
and apical thirds of the LV, using acquisition sequences
identical to those described above for patient imaging.
However, DE-MRI was not performed in volunteers.
2.3. Image analysis
2.3.1. Quantitative analysis of DE images
Epicardial and endocardial contours were drawn manually in
each short-axis DE image using cardiovascular image
analysis software (Argus, Siemens Medical Solutions,
Erlangen, Germany). Images were then manually thresholded
with custom analysis software (modified Argus, Siemens
Medical Solutions, Erlangen, Germany) using an interactive
region-filling tool to determine an appropriate intensity
threshold to differentiate viable (dark) from non-viable
(hyper-enhanced) tissue in each image (10).
Analysis of thresholded images was performed using
Matlab (v6.5, The MathWorks, Natick, MA, USA). Regional
variations in myocardial scar extent were examined using a
16-segment LV model (11). Percent Scar was defined as the
ratio of the number of non-viable pixels to the total number of
pixels within each segment. Transmurality was defined as the
average extent to which non-viable pixels originating at the
subendocardium traversed the LV wall in each segment (10),
and was computed in each thresholded image by analyzing
180 equiangular radial spokes centered at the LV center of
volume in that slice. For spokes in which non-viable pixels
originated at the subendocardium, Transmurality was com-
puted as the ratio of non-viable pixels to total pixels along the
spoke. Transmurality within a segment was defined as the
average of all spokes within that segment.
2.3.2. Quantitative analysis of cine MRI
Epicardial and endocardial borders were manually delineated
in cine MRI short axis images at end-diastole and end-systole
(using Argus software, Siemens Medical Solutions, Erlangen,
Germany). LV wall thickness at each time point was
computed using the centerline method (12). Absolute systolic
wall thickening was computed as the difference between
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end-systolic wall thickness and end-diastolic wall thickness.
Regional wall thickening was defined using the 16-segment
LV model described above.
2.3.3. Quantitative analysis of tagged images
LV circumferential strain was computed using harmonic
phase (HARP) analysis software (Diagnosoft, CA, USA)
(13). Briefly, HARP utilizes isolated spectral peaks in the
frequency-domain representation of tagged images. The
inverse Fourier transform of a spectral peak yields a complex
image whose phase is related to cardiac motion in one
direction. Analysis of two spectral peaks enables two-
dimensional cardiac motion to be determined, including
tracking individual points within the myocardium. The LV
mid-wall was specified by manually delineating the endocar-
dium and epicardium at end-systole at each short-axis level;
the mid-wall was then located automatically in all other
frames. Points lying on the mid-wall contour were tracked
automatically by the HARP software from end-diastole to
end-systole. LV circumferential strain in each short-axis
image was calculated based on the average motion of mid-
wall points. Regional circumferential strain was defined using
the 16-segment LV model defined above.
2.4. Data analysis
Results for each scar extent variable (Percent Scar and
Transmurality) from patient images were grouped into five
categories: 0%; 1%–25%; 26%–50%; 51%–75%; and 76%–
100%. Segments from healthy volunteer images served as a
sixth category (normal). Average systolic wall thickening and
average circumferential strain were computed for the seg-
ments in each category.
One-way analysis of variance with Tukey’s pairwise
comparison (14) was used to determine the significance of
differences between myocardial scar categories. Paired
student’s t-test was used to assess differences between
Percent Scar and Transmurality in all patient segments.
Linear mixed-model statistical methods (15) were used to
assess the significance of Percent Scar and Transmurality in
explaining regional variations in LV function (systolic wall
thickening and circumferential strain). Each measure of func-
tion was modeled separately, with both Percent Scar and
Transmurality included in each model as potential predictors.
Results are presented as mean ± standard deviation. In all
figures, error bars represent standard deviation.
3. Results
All patients demonstrated increased LV dimensions (end-
diastolic volume: 274 ± 11 ml) and impaired systolic function
(ejection fraction: 28 ± 11%, cardiac output of 5 ± 1 l/min).
Table 1 shows the end-diastolic volume, ejection fraction, and
cardiac output for each patient.
3.1. Relationship between scar extent and
systolic wall thickening
Figure 1A is a scatterplot of wall thickening versus Percent
Scar for all 368 segments from patient images (23
patients  16 segments, does not include segments from
healthy volunteers). Average systolic wall thickening within
each Percent Scar category is shown in Fig. 2, and average
systolic wall thickening within each Transmurality category is
shown in Fig. 3. Relative to normal segments, systolic wall
thickening was significantly reduced in all Percent Scar and
Transmurality categories containing patient data (0%; 1–
25%; 26–50%; 51–75%; and 76–100%).
In patients, systolic wall thickening was significantly
reduced above 50% Percent Scar, relative to the 0% category
(Fig. 2). However, systolic wall thickening was significantly
reduced above 25% Transmurality, relative to the 0%
category (Fig. 3). Although the 76–100% Transmurality
category did not differ significantly from segments without
scar (0%), the number of segments with 76–100% Trans-
murality was small (n = 8; 2%) when compared to the num-
ber with 0% scar (n = 130; 35%).
In a linear mixed-model regression of wall thickening,
which incorporated the effects of both Percent Scar and
Transmurality, neither of these scar variables was statistically
Table 1. Clinical characteristics of each patient
Patient Gender
Age
(years) EDV(ml) EF(%)
CO
(l/min)
1 M 59 321 17 4.2
2 M 47 198 33 4.3
3 M 39 341 23 5.7
4 M 54 307 30 6.2
5 M 68 183 45 5.4
6 M 64 412 19 6.6
7 M 58 350 17 4.7
8 F 68 171 17 2.6
9 M 48 277 22 5.7
10 M 54 247 22 4.3
11 M 73 231 34 4.3
12 M 45 389 09 2.7
13 F 43 154 32 5.0
14 M 67 334 31 7.7
15 M 29 259 48 7.7
16 M 71 193 56 7.2
17 M 64 332 26 6.9
18 M 72 363 12 3.9
19 M 65 244 25 4.0
20 F 55 202 29 4.5
21 M 72 235 32 4.5
22 M 75 351 22 4.8
23 M 72 205 36 4.4
Average 59 ± 13 274 ± 76 28 ± 11 5.1 ± 1.4
Gender, age (years), end-diastolic volume (EDV), ejection fraction (EF),
and cardiac output (CO). Also shown is the mean value (± standard
deviation) of each applicable parameter.
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significant: p = 0.15 for Percent Scar, p = 0.73 for Trans-
murality. However, when considered alone, Percent Scar was
a statistically significant predictor of wall thickening
(p < 0.0001, Fig. 1A). Similarly, Transmurality was a sig-
nificant predictor of wall thickening when considered alone
(p < 0.001).
3.2. Relationship between scar extent and
circumferential strain
A scatterplot of circumferential strain as a function of Percent
Scar for all 368 patient segments is displayed in Fig. 1B.
Circumferential strain within each Percent Scar category is
shown in Fig. 4, and circumferential strain within each
Transmurality category is shown in Fig. 5. Relative to Normal
segments, circumferential strain was significantly reduced in
all Percent Scar and Transmurality categories containing
patient data.
In patients, circumferential strain was significantly reduced
above 25% Percent Scar (Fig. 4). Similarly, circumferential
strain was significantly reduced above 25% Transmurality
(Fig. 5). However, as with wall thickening, the 76–100%
Transmurality category did not differ significantly from the
0% category, although the number of segments in this
Transmurality category was small (n = 8 of 368, 2%) when
compared to the number with 0% scar (n = 130, 35%).
In a linear mixed-model regression of circumferential
strain on the combined effects of Percent Scar and Trans-
murality, Percent Scar was statistically significant (p = 0.035,
Fig. 1B), but Transmurality was not (p = 0.77), with the
resultant model described by the equation, circumferential
Figure 1. (A) Overall effects of Percent Scar on absolute systolic
wall thickening in all segments taken from patient images
(n = 368). Despite the apparent spread in the data, wall thicken-
ing decreased significantly as Percent Scar increased (see text for
details). (B) Overall effects of Percent Scar on circumferential
strain in all segments taken from patient images. Circumferential
strain worsened significantly (became less negative) as Percent
Scar increased.
Figure 2. Average systolic wall thickening within each of the six
Percent Scar categories: normal from healthy volunteers and the
remaining categories from patient images.
Figure 3. Average systolic wall thickening within each of the six
Transmurality categories: normal from healthy volunteers and the
remaining categories from patient images.
Figure 4. Average circumferential strain within each of the six
Percent Scar categories: normal from healthy volunteers and the
remaining categories from patient images.
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strain = 8.6 + 0.067*(Percent Scar)  0.013*(Transmural-
lity). Similar to the wall thickening analysis, when considered
alone in a separate model, Transmurality became a statistically
significant predictor of circumferential strain (p = 0.003).
4. Discussion
In patients with chronic ischemic heart disease, regional LV
function is influenced by numerous factors, including the
presence of ischemic or hibernating myocardium and elevated
wall stress secondary to LV remodeling and heart failure (1).
Thus, it is not surprising that in the current study, we have
observed diminished regional LV function, as quantified
by either wall thickening or circumferential strain, even in
segments containing little or no non-viable myocardium
(Fig. 1A and 1B). Similarly, the myocardial segments in all
scar extent categories (0%; 1–25%; 26–50%; 51–75%; and
76–100%) demonstrated significantly impaired regional sys-
tolic function (Figs. 2–5), with mean wall thickening  1mm
and mean circumferential strain  8% in all categories,
when compared with segments containing only healthy myo-
cardium (normal); these results are consistent with a recently
published study (16).
Alternate imaging studies were available for comparison in
12 of 23 patients (52%), including rubidium (Rb) positron
emission tomography (PET) stress perfusion with fluoror-
deoxyglucose (FDG) viability imaging (n = 9; 39%), stress
myocardial perfusion single photon emission computed
tomography (SPECT) (n = 2; 9%), and stress echocardiog-
raphy (n = 1; 4%). By these modalities, 11 of 12 patients
(92%) exhibited non-viable myocardial segments (one patient
with scar by MRI was judged to have none by SPECT). In
addition, 4 of 12 patients (33%) exhibited ischemic segments,
which were estimated to cover 4–30% of the LV, and 1
patient (8%) exhibited hibernating segments, estimated to
cover 6% of the LV. Six patients (50%) had neither ischemic
nor hibernating segments, as assessed by these alternate
imaging modalities. Thus, at least in this subset of patients,
regional LV dysfunction could be attributed to the spectrum
of causes common to chronic ischemic heart disease.
4.1. Relationship between scar extent and
systolic wall thickening
Two previous studies have examined the relationship between
scar extent and regional LV function in subjects with single-
vessel coronary artery disease and have reported findings
similar to those of the current work. In a dog model of acute
myocardial infarction, Lieberman et al. showed reduced
segmental wall thickening when scar transmurality exceeded
20% (6). In a study of patients with single vessel coronary
disease and chronic infarcts studied an average of 5 months
post-revascularization, Marholdt et al. found significantly
reduced wall thickening in segments containing at least 50%
scar (7). Although these results seem disparate, their findings
closely mirror those of the current study, in which systolic
wall thickening was found to be significantly diminished in
segments with greater than 25% Transmurality or greater than
50% Percent Scar, relative to corresponding 0% categories
(Figs. 2 and 3). In their work, Lieberman et al. measured the
average transmural extent of infarction, identical to the
Transmurality index described in the current study, and their
results matched those of the current study using Trans-
murality. Marholdt et al., meanwhile, measured the relative
area of scar in each segment, identical to Percent Scar from
the current study (although they referred to their measure-
ments as transmurality); their results matched those of the
current study for Percent Scar. Therefore, discrepancies
between these previous studies might merely reflect differ-
ences in the parameters they measured, although the differ-
ences in population (dog versus human) and infarct age
(acute versus chronic) are also potential factors.
In this study, the range of wall thickening values exhibited
by normal segments, i.e. those from healthy volunteers, was
consistent with that of previous studies, which have reported
values from 4–7 mm depending on modality (17–21).
Furthermore, 303 of the 368 patient segments (82%)
exhibited absolute wall thickening < 2 mm, which has been
used previously as a threshold for discriminating normal from
hypokinetic segments (22, 23). In the remaining 65 patient
segments (18%), wall thickening was 2.9 ± 0.8 mm.
The use of absolute systolic wall thickening by the current
study was a departure from similar previous studies, which
have reported relative wall thickening (6, 7). However, due to
the thin LV wall (mean end-diastolic thickness 6.8 ± 2.1 mm)
and diminished wall thickening (<1 image pixel width on
average) exhibited by patients in this study, we felt that
relative thickening results would be misleading, in part
because small errors in delineating the myocardium could
lead to large errors in relative wall thickening. For example,
100 of 368 patient segments (27%) had an end-diastolic wall
Figure 5. Average circumferential strain within each of the six
Transmurality categories. The normal category represents data
from healthy volunteers, and the remaining categories from
patient images.
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thickness < 5.5 mm, which has been used previously as a
threshold for the absence of viability (24, 25); in these
segments, mean systolic wall thickening was 0.9 ± 1.2 mm
(18 ± 25%). In the remaining 268 segments (73%), i.e. those
with end-diastolic thickness 5.5 mm, mean systolic wall
thickening was 0.6 ± 1.6 mm (9 ± 21%). The difference
between these groups was not statistically significant for ab-
solute thickening (p = 0.26) but was statistically significant
for relative thickening (p = 0.001). Thus, relative thick-
ening underestimated the degree of dysfunction in the thin-
nest segments.
In a linear mixed-model analysis, neither Percent Scar nor
Transmurality were statistically significant predictors of
systolic wall thickening when both variables were included
in the model; however, each was significant when considered
alone in a separate model. This suggests that these variables
contribute redundant information with neither one standing
out as a superior predictor of wall thickening as a measure of
regional function.
4.2. Relationship between scar extent
and circumferential strain
Percent Scar and Transmurality affected circumferential strain
similarly, with significant reductions in strain when either scar
extent index exceeded 25% (Figs. 4 and 5). Although these
results are similar to those for wall thickening, circumferential
strain proved to be a more sensitive marker of increases in
Percent Scar, as demonstrated by Figs. 2 and 4. This finding is
consistent with a previous report, which showed circumfer-
ential strain to be more sensitive to the presence of
myocardial infarction than wall thickening (8).
In a linear mixed-model analysis including both Percent
Scar and Transmurality as potential predictors of circumfer-
ential strain, only Percent Scar was statistically significant.
Thus, at least in this type of analysis, this suggests that
Percent Scar is more predictive of strain than Transmurality.
Close inspection of the model equation for strain, presented
in the Results section, demonstrates that strain actually
improves (becomes more negative) when Transmurality is
nonzero. For example, considering two hypothetical segments
each with 50% Percent Scar, if the scar originates at the
subendocardium (i.e. nonzero Transmurality by our defini-
tion), strain will be improved relative to a segment in which
the scar does not originate at the subendocardium (i.e. Trans-
murality zero).
5. Conclusions
In patients with ischemic heart disease and multi-vessel
coronary artery disease, the relationship between myocardial
scar extent and regional LV function is consistent with that
reported previously in studies of subjects with single-vessel
disease. However, this relationship exhibits more variability
in multi-vessel disease patients due to the multiple confound-
ing factors associated with ischemic heart disease (e.g.
hibernating myocardium).
In this population, wall thickening is more sensitive to
changes in Transmurality than to changes in Percent Scar, but
circumferential strain shows equal sensitivity to both scar
extent indices. Furthermore, in general, circumferential
strain is more sensitive than wall thickening to increases in
scar extent.
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